Fate Therapeutics Stock Performance
| FATE Stock | USD 1.49 0.04 2.61% |
On a scale of 0 to 100, Fate Therapeutics holds a performance score of 5. The firm shows a Beta (market volatility) of 1.12, which means a somewhat significant risk relative to the market. Fate Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Fate Therapeutics is expected to follow. Please check Fate Therapeutics' semi variance, and the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Fate Therapeutics' price patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Fate Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Fate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | How does Fate Therapeutics Inc. generate profit in a changing economy - Financial News Forecasts For Smart Trading - jammulinksnews.com | 07/31/2025 |
2 | Disposition of 14466 shares by Bahram Valamehr of Fate Therapeutics at 1.0643 subject to Rule 16b-3 | 08/04/2025 |
3 | Biopharma layoffs rise as drugmakers tighten belts and reorganize | 08/18/2025 |
4 | Volume spikes in Fate Therapeutics Inc. stock what they mean - Global Markets Risk Adjusted Swing Trade Ideas - Newser | 09/05/2025 |
5 | Acquisition by Lee Michael Stewart of 55000 shares of Fate Therapeutics at 1.32 subject to Rule 16b-3 | 09/11/2025 |
6 | What analysts say about Fate Therapeutics Inc stock - July 2025 Recap High Yield Stock Recommendations - | 09/16/2025 |
7 | Is Fate Therapeutics Inc. stock affected by interest rate hikes - Weekly Trade Review Target Return Focused Stock Picks - The British Mountaineering Council | 09/26/2025 |
8 | Great week for Fate Therapeutics, Inc. institutional investors after losing 62 percent over the previous year | 10/01/2025 |
9 | Is Fate Therapeutics Inc. stock reversal real or fake - Market Movement Recap Step-by-Step Trade Execution Guides - newser.com | 10/15/2025 |
10 | Insider Trading | 10/20/2025 |
| Begin Period Cash Flow | 57 M | |
| Total Cashflows From Investing Activities | 12.2 M |
Fate Therapeutics Relative Risk vs. Return Landscape
If you would invest 124.00 in Fate Therapeutics on July 25, 2025 and sell it today you would earn a total of 25.00 from holding Fate Therapeutics or generate 20.16% return on investment over 90 days. Fate Therapeutics is currently generating 0.4817% in daily expected returns and assumes 6.3872% risk (volatility on return distribution) over the 90 days horizon. In different words, 57% of stocks are less volatile than Fate, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Fate Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fate Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Fate Therapeutics, and traders can use it to determine the average amount a Fate Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0754
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FATE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.39 actual daily | 57 57% of assets are less volatile |
Expected Return
| 0.48 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 5 95% of assets perform better |
Based on monthly moving average Fate Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fate Therapeutics by adding it to a well-diversified portfolio.
Fate Therapeutics Fundamentals Growth
Fate Stock prices reflect investors' perceptions of the future prospects and financial health of Fate Therapeutics, and Fate Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fate Stock performance.
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.25 | ||||
| Operating Margin | (19.39) % | ||||
| Current Valuation | (1.95 M) | ||||
| Shares Outstanding | 115.33 M | ||||
| Price To Earning | (4.35) X | ||||
| Price To Book | 0.53 X | ||||
| Price To Sales | 20.29 X | ||||
| Revenue | 13.63 M | ||||
| Gross Profit | (106.81 M) | ||||
| EBITDA | (176.58 M) | ||||
| Net Income | (186.26 M) | ||||
| Cash And Equivalents | 568.85 M | ||||
| Cash Per Share | 5.86 X | ||||
| Total Debt | 85.27 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 6.55 X | ||||
| Book Value Per Share | 2.28 X | ||||
| Cash Flow From Operations | (122.87 M) | ||||
| Earnings Per Share | (1.46) X | ||||
| Market Capitalization | 171.84 M | ||||
| Total Asset | 440.69 M | ||||
| Retained Earnings | (1.4 B) | ||||
| Working Capital | 253.39 M | ||||
| Current Asset | 47.4 M | ||||
| Current Liabilities | 14.68 M | ||||
About Fate Therapeutics Performance
By analyzing Fate Therapeutics' fundamental ratios, stakeholders can gain valuable insights into Fate Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Fate Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Fate Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.42) | (0.44) | |
| Return On Capital Employed | (0.52) | (0.55) | |
| Return On Assets | (0.42) | (0.44) | |
| Return On Equity | (0.58) | (0.61) |
Things to note about Fate Therapeutics performance evaluation
Checking the ongoing alerts about Fate Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fate Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fate Therapeutics had very high historical volatility over the last 90 days | |
| Fate Therapeutics may become a speculative penny stock | |
| Fate Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 13.63 M. Net Loss for the year was (186.26 M) with loss before overhead, payroll, taxes, and interest of (106.81 M). | |
| Fate Therapeutics currently holds about 568.85 M in cash with (122.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Fate Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Insider Trading |
- Analyzing Fate Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fate Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Fate Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fate Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fate Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fate Therapeutics' stock. These opinions can provide insight into Fate Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Fate Stock analysis
When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |